Classys "Cumulative Sales of Major Equipment Surpass 12,000 Units... Expansion of Production Facilities"

[Asia Economy Reporter Hyunseok Yoo] Classys announced on the 24th that the cumulative sales of devices such as Alpha, Ulfit, Aquapure, and Refit have each surpassed 1,000 units, with more than 12,000 units sold including Shurink.

Since Shurink surpassed 1,000 cumulative sales domestically in 2018, it has shown rapid growth. Currently, the cumulative global sales have exceeded 8,000 units, forming a global trend and raising expectations. The company plans to strengthen its brand and expand its main product lineup for products that have been consistently well-received in the global market since their launch.

A company official stated, “Alpha is a medical device that effectively reduces localized subcutaneous fat layers, providing safe treatment effects through natural apoptosis of fat cells. Utilizing Classys’ cooling control technology know-how, sales have increased annually since its launch in 2019. Aquapure is a medical device managed with four handpieces for acne suction, low-frequency stimulation, and temperature control, maintaining stable annual sales and establishing its position,” adding, “We will continue to promote the brand so that both medical professionals and the general public can recognize these well-received products in the field.”

Meanwhile, Classys is a company that directly develops, manufactures, and sells aesthetic medical devices. It supplies Classys brand products including its main product Shurink, Alpha, Scizer, and Tonerbe, as well as Cluderm brand products Ulfit, Aquapure, and Refit. To meet increasing demand, the company has recently acquired a factory and is expanding its production facilities.